OnQ Blog

VR therapy: How Rescape Innovation is providing emotional support for Covid-19 frontline workers

Aug 17, 2020

Qualcomm products mentioned within this post are offered by Qualcomm Technologies, Inc. and/or its subsidiaries.

As 5G continues to roll out around the globe, innovations in extended reality (XR) are transforming industries and creating brand new ones. In our ongoing series on XR, we explore how Qualcomm Technologies-powered devices are changing the way the world connects, computes, and communicates. In this installment, we take a look at the powerful work being done by Rescape Innovation, a company that’s using VR to support healthcare professionals battling the pandemic.

While COVID-19 continues to spread, doctors, nurses, EMTs, and others on the frontlines are facing extreme stress in high-pressure environments. Experts warn that while these medical professionals are at increased risk for burnout and mental health issues, therapeutic support is lacking.

To help, Rescape Innovation, a U.K.-based company that develops VR experiences to ease pain, stress, and anxiety, is offering its technology to support the mental wellbeing of frontline workers during the pandemic. The company's all-in-one VR kit, DR.VR, is now deployed in ten NHS hospitals across the U.K., offering distraction therapy and mindfulness exercises. The kit includes a tablet, VR headset, sanitary eye masks, noise-cancelling headphones, and a carry case. Plus, its connectivity operates within a closed system for an optimal VR experience.

“We knew that our product can help reduce stress and anxiety, and we wanted to see if it could be adapted quickly to help the frontline staff whose mental health has been affected,” said Rescape CEO Matt Wordley.

Examining the effect VR therapy has on frontline workers

To kick off the initiative, Rescape worked with the Cwm Taf Morgannwg University Health Board and the Centre for Trials Research at Cardiff University to test a scaled-down version of DR.VR for hospital staff. The content available for this version of the kit included guided breathing exercises and immersive distraction therapy experiences, like swimming underwater and exploring a rainforest. For two weeks, 21 frontline workers used the kit at work, at home, and before or after their shifts. 
 

Staff members reported that DR.VR was enjoyable to use and that they’d recommend it to colleagues to aid in relaxation and stress reduction. Since then, ten hospitals have signed up to provide VR for their frontline staff.

“We now hope to trial this on a much larger scale. We think it has real potential to help many more people and further our understanding of how VR can be used in the management of stress and anxiety,” said Dr. Kim Smallman, the Research Associate of Cardiff University’s Centre for Trials Research, in a press release.

Utilizing VR as distraction therapy

Rescape’s program for frontline healthcare workers is just the latest use for its VR technology. Since the company’s inception in 2018, children, patients who are needle-phobic, and those nervous about undergoing MRI scans have used DR.VR. After completing an experience, users sleep for longer periods of time, are more receptive to new information, and are significantly less anxious. And because VR is a non-intrusive alternative to opioids and other medications, users don’t experience debilitating side effects. 
 
“When people practice mindfulness, it takes six to eight months before they see any benefits,” said Rescape Product Development Director Kevin Moss. “With VR, we see them access those same benefits far, far quicker. Those instant effects after people come out of VR, that’s really important.”
 

When developing the DR.VR kit, Rescape kept certain healthcare-specific challenges in mind, such as unreliable Wi-Fi connectivity in hospitals, infection control, VR inexperience for staff and patients, and the need to create immersive content that doesn’t induce motion sickness. To address these pain points, the company created a closed system that doesn’t depend on Wi-Fi and can be used anywhere within a hospital. It also included 50 VR sanitary eyes masks in each kit, as well as an easy-to-use tablet that enables healthcare professionals to control the content and gather data on patients’ experiences. 

Rescape also counts on lightweight Pico G2 headsets to display its high-resolution VR experiences. Powered by the Qualcomm Snapdragon 835 Mobile Platform, the headset’s GPU delivers up to 25 percent faster graphics rendering and 60x more display colors when compared to its previous generation. The platform also supports 3 Degrees of Freedom (3DoF), allowing bedridden patients to immerse themselves by simply turning their heads or tilting up and down. A pair of noise-cancelling headphones completes the set, ensuring patients stay engaged without any distractions from reality. Altogether, this provides a more interactive and realistic VR experience. 

Integrating 5G in the near future

5G opens up a variety of opportunities for companies like Rescape, including the potential to incorporate biometrics into the device and control the end-to-end communication between the tablet and the headset. And when 5G works together with on-device processing and edge cloud processing, new immersive experiences like boundless XR are possible, delivering sleek, photorealistic VR to headsets. With improved connectivity, Rescape can design larger, more detailed, and more intelligent VR content. 
 
“People use VR because the content is amazing,” Wordley said. “5G will be a game changer in how much and how quickly content can be delivered.”

For now, Rescape is focused on perfecting its completely immersive VR for the millions of healthcare workers on the frontlines of the pandemic. “Our VR delivers amazing outcomes for patients,” he said. “We want to use that technology to make a huge social impact.”

Qualcomm Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries.

 

Opinions expressed in the content posted here are the personal opinions of the original authors, and do not necessarily reflect those of Qualcomm Incorporated or its subsidiaries ("Qualcomm"). Qualcomm products mentioned within this post are offered by Qualcomm Technologies, Inc. and/or its subsidiaries. The content is provided for informational purposes only and is not meant to be an endorsement or representation by Qualcomm or any other party. This site may also provide links or references to non-Qualcomm sites and resources. Qualcomm makes no representations, warranties, or other commitments whatsoever about any non-Qualcomm sites or third-party resources that may be referenced, accessible from, or linked to this site.

The OnQ Team

Related News

©2020 Qualcomm Technologies, Inc. and/or its affiliated companies.

References to "Qualcomm" may mean Qualcomm Incorporated, or subsidiaries or business units within the Qualcomm corporate structure, as applicable.

Qualcomm Incorporated includes Qualcomm's licensing business, QTL, and the vast majority of its patent portfolio. Qualcomm Technologies, Inc., a wholly-owned subsidiary of Qualcomm Incorporated, operates, along with its subsidiaries, substantially all of Qualcomm's engineering, research and development functions, and substantially all of its products and services businesses. Qualcomm products referenced on this page are products of Qualcomm Technologies, Inc. and/or its subsidiaries.

Materials that are as of a specific date, including but not limited to press releases, presentations, blog posts and webcasts, may have been superseded by subsequent events or disclosures.

Nothing in these materials is an offer to sell any of the components or devices referenced herein.